Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Arrowhead, Janssen sign $3.7bn license and collaboration deal
Image: Arrowhead and Janssen will develop and commercialize hepatitis B virus treatment called ARO-HBV. Photo: courtesy of sscreations / FreeDigitalPhotos.net.
Image: Arrowhead and Janssen will develop and commercialize hepatitis B virus treatment called ARO-HBV. Photo: courtesy of sscreations / FreeDigitalPhotos.net.